Ovarian Cancer Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
1. EXECUTIVE SUMMARY
2. GLOBAL OVARIAN CANCER DIAGNOSTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Ovarian Cancer Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Ovarian Cancer Diagnostics Market by Product
3.3.1: Instruments
3.3.2: Kits and Reagents
3.4: Global Ovarian Cancer Diagnostics Market by Diagnosis Type
3.4.1: Imaging
3.4.2: Blood Test
3.4.3: Biopsy
3.4.4: Others
3.5: Global Ovarian Cancer Diagnostics Market by Cancer Type
3.5.1: Epithelial Tumor
3.5.2: Germ Cell
3.5.3: Stromal Cell Tumor
3.6: Global Ovarian Cancer Diagnostics Market by End Use
3.6.1: Cancer Diagnostic Centers
3.6.2: Hospital Laboratories
3.6.3: Research Institutes
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Ovarian Cancer Diagnostics Market by Region
4.2: North American Ovarian Cancer Diagnostics Market
4.2.2: North American Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
4.3: European Ovarian Cancer Diagnostics Market
4.3.1: European Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
4.3.2: European Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
4.4: APAC Ovarian Cancer Diagnostics Market
4.4.1: APAC Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
4.4.2: APAC Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
4.5: ROW Ovarian Cancer Diagnostics Market
4.5.1: ROW Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
4.5.2: ROW Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Product
6.1.2: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Diagnosis Type
6.1.3: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Cancer Type
6.1.4: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by End Use
6.1.5: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Region
6.2: Emerging Trends in the Global Ovarian Cancer Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Ovarian Cancer Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovarian Cancer Diagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: F. Hoffmann-La Roche
7.2: Tosoh
7.3: Luminex Corporation
7.4: Quest Diagnostics Incorporated
7.5: Thermo Fisher Scientific
7.6: Ngenebio
7.7: Abbott
7.8: Siemens healthcare
7.9: Myriad genetics
7.10: Bio-rad laboratories
2. GLOBAL OVARIAN CANCER DIAGNOSTICS MARKET : MARKET DYNAMICS
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. MARKET TRENDS AND FORECAST ANALYSIS FROM 2018 TO 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Ovarian Cancer Diagnostics Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Ovarian Cancer Diagnostics Market by Product
3.3.1: Instruments
3.3.2: Kits and Reagents
3.4: Global Ovarian Cancer Diagnostics Market by Diagnosis Type
3.4.1: Imaging
3.4.2: Blood Test
3.4.3: Biopsy
3.4.4: Others
3.5: Global Ovarian Cancer Diagnostics Market by Cancer Type
3.5.1: Epithelial Tumor
3.5.2: Germ Cell
3.5.3: Stromal Cell Tumor
3.6: Global Ovarian Cancer Diagnostics Market by End Use
3.6.1: Cancer Diagnostic Centers
3.6.2: Hospital Laboratories
3.6.3: Research Institutes
3.6.4: Others
4. MARKET TRENDS AND FORECAST ANALYSIS BY REGION FROM 2018 TO 2030
4.1: Global Ovarian Cancer Diagnostics Market by Region
4.2: North American Ovarian Cancer Diagnostics Market
4.2.2: North American Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
4.3: European Ovarian Cancer Diagnostics Market
4.3.1: European Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
4.3.2: European Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
4.4: APAC Ovarian Cancer Diagnostics Market
4.4.1: APAC Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
4.4.2: APAC Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
4.5: ROW Ovarian Cancer Diagnostics Market
4.5.1: ROW Ovarian Cancer Diagnostics Market by Diagnosis Type: Imaging, Blood Test, Biopsy, and Others
4.5.2: ROW Ovarian Cancer Diagnostics Market by End Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, and Others
5. COMPETITOR ANALYSIS
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. GROWTH OPPORTUNITIES AND STRATEGIC ANALYSIS
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Product
6.1.2: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Diagnosis Type
6.1.3: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Cancer Type
6.1.4: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by End Use
6.1.5: Growth Opportunities for the Global Ovarian Cancer Diagnostics Market by Region
6.2: Emerging Trends in the Global Ovarian Cancer Diagnostics Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Ovarian Cancer Diagnostics Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ovarian Cancer Diagnostics Market
6.3.4: Certification and Licensing
7. COMPANY PROFILES OF LEADING PLAYERS
7.1: F. Hoffmann-La Roche
7.2: Tosoh
7.3: Luminex Corporation
7.4: Quest Diagnostics Incorporated
7.5: Thermo Fisher Scientific
7.6: Ngenebio
7.7: Abbott
7.8: Siemens healthcare
7.9: Myriad genetics
7.10: Bio-rad laboratories
